Back to search

Article

Real-world Safety and Efficacy of Dimethyl Fumarate in Relapse-Remitting Multiple Sclerosis Patients: A Regional Cohort Report of the Iranian Patients

2026-08-03

Abstract excerpt

<h4>Background</h4> Real-world evidence evaluating the long-term effectiveness and safety of dimethyl fumarate (DMF) in relapsing-remitting multiple sclerosis (RRMS) remains limited, particularly in Middle Eastern populations. Furthermore, whether previous exposure to disease-modifying therapies influences longitudinal treatment response has not been adequately characterized. We evaluated the real-world effective...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3c9c996d-23a9-5332-aa40-488b3d54bf6d
DOI
10.64898/2026.07.31.26359413
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Real-world Safety and Efficacy of Dimethyl Fumarate in Relapse-Remitting Multiple Sclerosis Patients: A Regional Cohort Report of the Iranian PatientsDOI 10.64898/2026.07.31.26359413
Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple SclerosisSemantic proximity
Application of pharmacogenomics to investigate adverse drug reactions to the disease-modifying treatments for multiple sclerosis: a case-control study protocol for dimethyl fumarate-induced lymphopenia.Semantic proximity
Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent MechanismsSemantic proximity
Dimethyl fumarate alters microglia phenotype and protects neurons against proinflammatory toxic microenvironments.Semantic proximity
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.Semantic proximity
A novel fumarate, isosorbide di-(methyl fumarate) (IDMF), replicates astrocyte transcriptome responses to dimethyl fumarate (DMF) but specifically down-regulates genes linked to a reactive phenotype.Semantic proximity
Interval reduction in MRI lesion burden in relapsing-remitting multiple sclerosis following an integrative alternative medicine regimen: a case reportSemantic proximity
Repurposing dimethyl fumarate as an antiepileptogenic and disease-modifying treatment for drug-resistant epilepsySemantic proximity
The Emerging Role of Dimethyl Fumarate in Alzheimer’s Disease—A Systematic Review of Available Preclinical StudiesSemantic proximity
Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosisSemantic proximity
Comparative effectiveness of natalizumab and fingolimod and injectable therapies in patients with pediatric multiple sclerosis: A registry-based retrospective cohort studySemantic proximity
The role of age in choosing high-efficacy treatment for multiple sclerosis – an Austrian MS Database studySemantic proximity
Select a neighboring publication to make it the new centre.